申请人:Rhone Poulenc Industries
公开号:US04363909A1
公开(公告)日:1982-12-14
Isoquinoline derivatives of the formula ##STR1## wherein the symbol A.sub.1 represents an isoquinol-8-yl, 3-methylisoquinol-8-yl, 3-hydroxymethylisoquinol-5-yl, 3-carboxymethylisoquinol-5-yl, quinol-5-yl, thienopyridyl, benzimidazolyl, thienyl or thiazolyl radical, a 4-(or 5-)carboxyalkylthiazol-2-yl radical in which the alkyl moiety is linear or branched and contains 1 to 4 carbon atoms, or a 1,3,4-thiadiazol-2-yl, pyrazolyl, imidazolyl, pyrimidinyl, pyridazinyl or pyrazinyl radical, monocyclic heterocyclic rings within the definition of A.sub.1 being optionally substituted by a linear or branched alkyl radical containing 1 to 4 carbon atoms, in the (S) or (R,S) form or mixtures thereof, and salts thereof possess useful pharmocological properties, in particular antiviral activity.
公式为##STR1##的异喹啉衍生物,其中符号A.sub.1代表异喹啉-8-基、3-甲基异喹啉-8-基、3-羟甲基异喹啉-5-基、3-羧甲基异喹啉-5-基、喹啉-5-基、噻吩吡啶基、苯并咪唑基、噻吩基或噻唑基基团,一种4-(或5-)羧基烷基噻唑-2-基基团,其中烷基部分是直链或支链且含有1至4个碳原子,或者是1,3,4-噻二唑-2-基、吡唑基、咪唑基、嘧啶基、吡啶嗪基或吡啶基基团,A.sub.1定义内的单环杂环环可选择地被含有1至4个碳原子的直链或支链烷基基团取代,以(S)或(R,S)形式或它们的混合物,以及其盐具有有用的药理特性,特别是抗病毒活性。